NCT03623581View on ClinicalTrials.gov

Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)

PHASE2UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

December 30, 2022

Conditions
Alveolar Soft Part Sarcoma
Interventions
BIOLOGICAL

GB226

3mg/kg treat every 2 weeks

Trial Locations (1)

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Genor Biopharma Co., Ltd.

INDUSTRY